Interstitial Lung Disease and Mediastinal Lymph Nodes: A Computed Tomography-based Biomarker beyond Nosological and Etiological Borders?
- PMID: 30653924
- PMCID: PMC6467315
- DOI: 10.1164/rccm.201811-2123LE
Interstitial Lung Disease and Mediastinal Lymph Nodes: A Computed Tomography-based Biomarker beyond Nosological and Etiological Borders?
Comment in
-
Reply to Lescoat et al. and to Khamis et al.Am J Respir Crit Care Med. 2019 Apr 15;199(8):1041-1042. doi: 10.1164/rccm.201811-2208LE. Am J Respir Crit Care Med. 2019. PMID: 30653922 Free PMC article. No abstract available.
Comment on
-
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.Am J Respir Crit Care Med. 2019 Mar 15;199(6):747-759. doi: 10.1164/rccm.201804-0761OC. Am J Respir Crit Care Med. 2019. PMID: 30216085 Free PMC article.
References
-
- Adegunsoye A, Oldham JM, Bonham C, Hrusch C, Nolan P, Klejch W, et al. Prognosticating outcomes in interstitial lung disease by mediastinal lymph node assessment: an observational cohort study with independent validation. Am J Respir Crit Care Med. [online ahead of print] 14 Sep 2018; DOI: 10.1164/rccm.201804-0761OC. - PMC - PubMed
-
- Khanna D, Denton CP, Jahreis A, van Laar JM, Frech TM, Anderson ME, et al. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet. 2016;387:2630–2640. - PubMed
-
- Ngom A, Dumont P, Diot P, Lemarié E. Benign mediastinal lymphadenopathy in congestive heart failure. Chest. 2001;119:653–656. - PubMed
-
- Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, et al. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev. 2014;13:151–156. - PubMed
